Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis
An Open-label Pilot Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis
Sponsor: Tufts Medical Center
Terminated
lack of efficacy
Other terminated trials from Tufts Medical Center
Other Psoriasis trials with similar outcome
Listed as NCT01948271, this PHASE1 trial focuses on Psoriasis and remains terminated or withdrawn. Sponsored by Tufts Medical Center, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tufts Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .